8h
Investing News Network on MSNStem Cell Stocks: 10 Biggest NASDAQ Companies in 2025Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...
In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...
mRNA vaccination against SARS-CoV-2 was tied to a 57% and 73% lower risk of having at least one or two long-COVID symptoms, ...
Discovering ultra-conserved elements in the genome and their role in limiting protein production in mice testes.
SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026 Joint R&D project between SK and CEPI includes up to ...
19h
Vietnam Investment Review on MSNAIM Vaccine s mRNA Shingles Vaccine Submits Clinical Application to the U SAnother Step Forward in Global Expansion HONG KONG, Feb. 25, 2025 /PRNewswire/ -- As global capital reassesses the investment value of innovative Chinese companies, the development of innovative ...
Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...
Recent positive lab confirmation of Smart mRNA functionality is a tremendous milestone for the Company. This marks a ...
By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...
Allspring Global Investments Holdings LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 12.2% in the fourth quarter, Holdings Channel reports. The firm owned 15,368 shares of ...
Scientists explored the differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccines, and other viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results